Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
暂无分享,去创建一个
M. Karsdal | D. Maixnerova | V. Tesar | M. Suchanek | Z. Hruskova | N. Sparding | F. Genovese | M. Neprašová | H. Kopřivová | M. Kollar
[1] M. Karsdal,et al. Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients , 2020, Clinical kidney journal.
[2] M. Karsdal,et al. A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease , 2018, PloS one.
[3] M. Karsdal,et al. Non-invasive quantification of collagen turnover in renal transplant recipients , 2017, PloS one.
[4] M. Karsdal,et al. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] M. Karsdal,et al. Collagen Type III and VI Turnover in Response to Long-Term Immobilization , 2015, PloS one.
[6] M. Karsdal,et al. Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] M. Karsdal,et al. Plasma Pro‐C3 (N‐terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C , 2015, Liver international (Print).
[8] M. Karsdal,et al. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? , 2014, Fibrogenesis & tissue repair.
[9] M. Karsdal,et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. , 2013, American journal of translational research.
[10] S. Barbour,et al. Risk stratification of patients with IgA nephropathy. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] Y. Iwamoto,et al. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] P. Boor,et al. Renal fibrosis: novel insights into mechanisms and therapeutic targets , 2010, Nature Reviews Nephrology.
[13] A. Parrish,et al. Role of matrix metalloproteinases in renal pathophysiologies. , 2007, American journal of physiology. Renal physiology.
[14] T. Hosoya,et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. , 2001, Clinical nephrology.
[15] E. Adachi,et al. Collagen IV is upregulated in chronic transplant nephropathy. , 2001, Transplantation proceedings.
[16] C. Brown,et al. Urinary and serum type III collagen: markers of renal fibrosis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] J. Floege,et al. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. , 1997, Kidney international.
[18] M. Haubitz,et al. Activation of the acute phase response and complement C3 in patients with IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] P. S. St. John,et al. Laminin distribution in developing glomerular basement membranes. , 1993, Kidney international.